ERBB2 and breast carcinoma: In another 1993 study by Press et al., the expression of HER2 was evaluated in 704 node-negative breast cancer patients, and it was noted that women with breast cancer and high HER2 overexpression had a risk of recurrence 9.5 times greater than those with normal HER2 expression [45].